Financial Advisory Group’s Avita Medical RCEL Stock Holding History

Financial Advisory Group’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$249K	Buy	15,521 +2,500	+19%	+$40.5K	0.04%	78
2023 Q4	$179K	Sell	13,021 -5,000	-28%	-$57.3K	0.03%	86
2023 Q3	$263K	Buy	18,021 +910	+5%	+$15.4K	0.05%	76
2023 Q2	$291K	Hold	17,111	–	–	0.06%	71
2023 Q1	$239K	Buy	17,111 +4,915	+40%	+$52.3K	0.05%	76
2022 Q4	$80K	Buy	12,196 +2,033	+20%	+$12.2K	0.02%	87
2022 Q3	$54K	Buy	+10,163	New	+$62.8K	0.01%	90
2020 Q2	–	Sell	-3,160	Closed	-$98K	–	69
2020 Q1	$98K	Buy	+3,160	New	+$131K	0.03%	65

Other funds holding RCEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Financial Advisory Group's RCEL Position: Q1 2024 in Review

Financial Advisory Group increased its Avita Medical (RCEL) stake by 19% in Q1 2024, buying an estimated $40.5K and bringing the position to 15,521 shares worth $249K. The position accounts for 0.04% of the portfolio, ranked #78.

Financial Advisory Group first reported a position in RCEL in Q1 2020 and has held it in 8 quarters since. The position peaked at $291K in Q2 2023. 82 funds tracked by Wall St. Rank hold RCEL as of Q1 2024.

Financial Advisory Group held 15,521 shares of Avita Medical worth $249K as of Q1 2024.
Financial Advisory Group bought 2,500 Avita Medical shares in Q1 2024, an estimated $40.5K.
Avita Medical made up 0.04% of Financial Advisory Group's portfolio in Q1 2024, its #78 holding.
Financial Advisory Group first reported a position in Avita Medical in Q1 2020 and has held it in 8 quarters since.
Financial Advisory Group's Avita Medical position peaked at $291K in Q2 2023.
82 funds tracked by Wall St. Rank held Avita Medical as of Q1 2024.

Based on Financial Advisory Group's 13F filing for Q1 2024, filed 10 May 2024.